We've found
184,457
clinical trials
Neurology, Oncology Clinical Trial
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Nivolumab and Yttrium Y 90 Glass Microspheres in Treating Patients With Advanced Liver Cancer
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Neoadjuvant Nivolumab With and Without Urelumab in Patients With Cisplatin-Ineligible Muscle-Invasive Urothelial Carcinoma of the Bladder
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Neoadjuvant Nivolumab With and Without Urelumab in Patients With Cisplatin-Ineligible Muscle-Invasive Urothelial Carcinoma of the Bladder
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Study of Abemaciclib in Dedifferentiated Liposarcoma
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Immunology / Infectious Diseases, Oncology Clinical Trial
Expanded Access Protocol for Tabelecleucel in Subjects With EBV-Associated Viremia or Malignancies
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Immunology / Infectious Diseases, Oncology Clinical Trial
Expanded Access Protocol for Tabelecleucel in Subjects With EBV-Associated Viremia or Malignancies
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Advanced Solid Neoplasms Clinical Trial
A Study of Safety, Pharmacokinetics and Pharmacodynamics of JNJ-64457107 in Participants With Advanced Stage Tumors
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Cystic Fibrosis Clinical Trial
Monitoring Response to Orkambi in Cystic Fibrosis Lung Disease by Inhaled Xenon MRI
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Study of the Efficacy, Safety, and Pharmacokinetics of SM88 in Patients With Prostate Cancer
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology, Orthopedics / Podiatry Clinical Trial
Blepharospasm Tools
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology, Orthopedics / Podiatry Clinical Trial
Blepharospasm Tools
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
A Study of T-VEC (Talimogene Laherparepvec) With or Without Radiotherapy for Melanoma, Merkel Cell Carcinoma, or Other Solid Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Hypoplastic Left Heart Syndrome (HLHS) Clinical Trial
National Collaborative to Improve Care of Children With Complex Congenital Heart Disease
Status: Enrolling,
Phase
Updated: 4/9/2018
Click here to add this to my saved trials
Hypoplastic Left Heart Syndrome (HLHS) Clinical Trial
National Collaborative to Improve Care of Children With Complex Congenital Heart Disease
Status: Enrolling,
Phase
Updated: 4/9/2018
Click here to add this to my saved trials
Hypoplastic Left Heart Syndrome (HLHS) Clinical Trial
National Collaborative to Improve Care of Children With Complex Congenital Heart Disease
Status: Enrolling,
Phase
Updated: 4/9/2018
Click here to add this to my saved trials
Hypoplastic Left Heart Syndrome (HLHS) Clinical Trial
National Collaborative to Improve Care of Children With Complex Congenital Heart Disease
Status: Enrolling,
Phase
Updated: 4/9/2018
Click here to add this to my saved trials
Hypoplastic Left Heart Syndrome (HLHS) Clinical Trial
National Collaborative to Improve Care of Children With Complex Congenital Heart Disease
Status: Enrolling,
Phase
Updated: 4/9/2018
Click here to add this to my saved trials
Hypoplastic Left Heart Syndrome (HLHS) Clinical Trial
National Collaborative to Improve Care of Children With Complex Congenital Heart Disease
Status: Enrolling,
Phase
Updated: 4/9/2018
Click here to add this to my saved trials
Hypoplastic Left Heart Syndrome (HLHS) Clinical Trial
National Collaborative to Improve Care of Children With Complex Congenital Heart Disease
Status: Enrolling,
Phase
Updated: 4/9/2018
Click here to add this to my saved trials
Hypoplastic Left Heart Syndrome (HLHS) Clinical Trial
National Collaborative to Improve Care of Children With Complex Congenital Heart Disease
Status: Enrolling,
Phase
Updated: 4/9/2018
Click here to add this to my saved trials
Hypoplastic Left Heart Syndrome (HLHS) Clinical Trial
National Collaborative to Improve Care of Children With Complex Congenital Heart Disease
Status: Enrolling,
Phase
Updated: 4/9/2018
Click here to add this to my saved trials
Hypoplastic Left Heart Syndrome (HLHS) Clinical Trial
National Collaborative to Improve Care of Children With Complex Congenital Heart Disease
Status: Enrolling,
Phase
Updated: 4/9/2018
Click here to add this to my saved trials
Hypoplastic Left Heart Syndrome (HLHS) Clinical Trial
National Collaborative to Improve Care of Children With Complex Congenital Heart Disease
Status: Enrolling,
Phase
Updated: 4/9/2018
Click here to add this to my saved trials
Glaucoma Clinical Trial
Effectiveness and Safety of Timolol and Dorzolamide Loaded Contact Lenses
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Solid Tumor Cancer Surgery With or Without Intraoperative Imaging: A Registry
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Carcinoma Breast Stage IV Clinical Trial
A Study of Pembrolizumab With Carboplatin and Gemcitabine in Patients With Metastatic Triple Negative Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Carcinoma Breast Stage IV Clinical Trial
A Study of Pembrolizumab With Carboplatin and Gemcitabine in Patients With Metastatic Triple Negative Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Colorectal Cancer Clinical Trial
Evaluation of MM-151 + Nal-IRI + 5-FU + Leucovorin in RAS/RAF Wild-type Metastatic Colorectal Cancer
Status: Enrolling,
Phase
I, II
Updated: 12/1/2016
Click here to add this to my saved trials
Bacterial Infections Clinical Trial
Dose-finding, Pharmacokinetics, and Safety of VABOMERE in Pediatric Subjects With Bacterial Infections
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Hepatocellular Carcinoma Clinical Trial
Study of Pembrolizumab (MK-3475) as Monotherapy in Participants With Advanced Hepatocellular Carcinoma (MK-3475-224/KEYNOTE-224)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Hepatocellular Carcinoma Clinical Trial
Study of Pembrolizumab (MK-3475) as Monotherapy in Participants With Advanced Hepatocellular Carcinoma (MK-3475-224/KEYNOTE-224)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Hepatocellular Carcinoma Clinical Trial
Study of Pembrolizumab (MK-3475) as Monotherapy in Participants With Advanced Hepatocellular Carcinoma (MK-3475-224/KEYNOTE-224)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Hepatocellular Carcinoma Clinical Trial
Study of Pembrolizumab (MK-3475) as Monotherapy in Participants With Advanced Hepatocellular Carcinoma (MK-3475-224/KEYNOTE-224)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Triple Negative Breast Cancer (TNBC) Clinical Trial
Study of Pembrolizumab (MK-3475) Plus Chemotherapy vs. Placebo Plus Chemotherapy for Previously Untreated Locally Recurrent Inoperable or Metastatic Triple Negative Breast Cancer (MK-3475-355/KEYNOTE-355)
Status: Enrolling,
Phase
III
Updated: 4/26/2018
Click here to add this to my saved trials
Triple Negative Breast Cancer (TNBC) Clinical Trial
Study of Pembrolizumab (MK-3475) Plus Chemotherapy vs. Placebo Plus Chemotherapy for Previously Untreated Locally Recurrent Inoperable or Metastatic Triple Negative Breast Cancer (MK-3475-355/KEYNOTE-355)
Status: Enrolling,
Phase
III
Updated: 4/26/2018
Click here to add this to my saved trials
Triple Negative Breast Cancer (TNBC) Clinical Trial
Study of Pembrolizumab (MK-3475) Plus Chemotherapy vs. Placebo Plus Chemotherapy for Previously Untreated Locally Recurrent Inoperable or Metastatic Triple Negative Breast Cancer (MK-3475-355/KEYNOTE-355)
Status: Enrolling,
Phase
III
Updated: 4/26/2018
Click here to add this to my saved trials
Triple Negative Breast Cancer (TNBC) Clinical Trial
Study of Pembrolizumab (MK-3475) Plus Chemotherapy vs. Placebo Plus Chemotherapy for Previously Untreated Locally Recurrent Inoperable or Metastatic Triple Negative Breast Cancer (MK-3475-355/KEYNOTE-355)
Status: Enrolling,
Phase
III
Updated: 4/26/2018
Click here to add this to my saved trials
Triple Negative Breast Cancer (TNBC) Clinical Trial
Study of Pembrolizumab (MK-3475) Plus Chemotherapy vs. Placebo Plus Chemotherapy for Previously Untreated Locally Recurrent Inoperable or Metastatic Triple Negative Breast Cancer (MK-3475-355/KEYNOTE-355)
Status: Enrolling,
Phase
III
Updated: 4/26/2018
Click here to add this to my saved trials
Triple Negative Breast Cancer (TNBC) Clinical Trial
Study of Pembrolizumab (MK-3475) Plus Chemotherapy vs. Placebo Plus Chemotherapy for Previously Untreated Locally Recurrent Inoperable or Metastatic Triple Negative Breast Cancer (MK-3475-355/KEYNOTE-355)
Status: Enrolling,
Phase
III
Updated: 4/26/2018
Click here to add this to my saved trials
Triple Negative Breast Cancer (TNBC) Clinical Trial
Study of Pembrolizumab (MK-3475) Plus Chemotherapy vs. Placebo Plus Chemotherapy for Previously Untreated Locally Recurrent Inoperable or Metastatic Triple Negative Breast Cancer (MK-3475-355/KEYNOTE-355)
Status: Enrolling,
Phase
III
Updated: 4/26/2018
Click here to add this to my saved trials
Triple Negative Breast Cancer (TNBC) Clinical Trial
Study of Pembrolizumab (MK-3475) Plus Chemotherapy vs. Placebo Plus Chemotherapy for Previously Untreated Locally Recurrent Inoperable or Metastatic Triple Negative Breast Cancer (MK-3475-355/KEYNOTE-355)
Status: Enrolling,
Phase
III
Updated: 4/26/2018
Click here to add this to my saved trials
Triple Negative Breast Cancer (TNBC) Clinical Trial
Study of Pembrolizumab (MK-3475) Plus Chemotherapy vs. Placebo Plus Chemotherapy for Previously Untreated Locally Recurrent Inoperable or Metastatic Triple Negative Breast Cancer (MK-3475-355/KEYNOTE-355)
Status: Enrolling,
Phase
III
Updated: 4/26/2018
Click here to add this to my saved trials
Clinical Trial
Changes in Footwear Comfort and Performance in High School Football Players
Status: Enrolling
Updated: 8/3/2016
Click here to add this to my saved trials
Oncology Clinical Trial
Olaparib With or Without Atezolizumab in Treating Patients With Locally Advanced or Metastatic Non-HER2-Positive Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Olaparib With or Without Atezolizumab in Treating Patients With Locally Advanced or Metastatic Non-HER2-Positive Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Olaparib With or Without Atezolizumab in Treating Patients With Locally Advanced or Metastatic Non-HER2-Positive Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Olaparib With or Without Atezolizumab in Treating Patients With Locally Advanced or Metastatic Non-HER2-Positive Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Olaparib With or Without Atezolizumab in Treating Patients With Locally Advanced or Metastatic Non-HER2-Positive Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Olaparib With or Without Atezolizumab in Treating Patients With Locally Advanced or Metastatic Non-HER2-Positive Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Olaparib With or Without Atezolizumab in Treating Patients With Locally Advanced or Metastatic Non-HER2-Positive Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Olaparib With or Without Atezolizumab in Treating Patients With Locally Advanced or Metastatic Non-HER2-Positive Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Alzheimer Disease Clinical Trial
BI 425809 in Patients With Cognitive Impairment Due to Alzheimer's Disease.
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Alzheimer Disease Clinical Trial
BI 425809 in Patients With Cognitive Impairment Due to Alzheimer's Disease.
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Alzheimer Disease Clinical Trial
BI 425809 in Patients With Cognitive Impairment Due to Alzheimer's Disease.
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Alzheimer Disease Clinical Trial
BI 425809 in Patients With Cognitive Impairment Due to Alzheimer's Disease.
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Schizophrenia Clinical Trial
Clinical Trial of BI 425809 Effect on Cognition and Functional Capacity in Schizophrenia
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Schizophrenia Clinical Trial
Clinical Trial of BI 425809 Effect on Cognition and Functional Capacity in Schizophrenia
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Schizophrenia Clinical Trial
Clinical Trial of BI 425809 Effect on Cognition and Functional Capacity in Schizophrenia
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Optune Delivered Electric Field Therapy and Bevacizumab in Treating Patients With Recurrent or Progressive Grade 2 or 3 Meningioma
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
RHEUMATOID ARTHRITIS Clinical Trial
The Corrona RA Data Collection Program
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Pancreatic Cancer Clinical Trial
Phase II Randomized Trial of mFOLFIRINOX +/- Ramucirumab in Advanced Pancreatic Cancer
Status: Enrolling,
Phase
II
Updated: 4/23/2018
Click here to add this to my saved trials
Hantaan Virus Clinical Trial
A Single-blind Study to Evaluate the Safety, Tolerability, and Immunogenicity of a Hantaan Puumala Virus DNA Vaccine
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Knee Osteoarthritis Clinical Trial
Liposomal Bupivacaine vs Adductor Canal Block in Total Knee Arthroplasty
Status: Enrolling,
Phase
IV
Updated: 10/11/2017
Click here to add this to my saved trials
Keratolysis Clinical Trial
Vision Restoration With a Collagen Crosslinked Boston Keratoprosthesis Unit
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Keratolysis Clinical Trial
Vision Restoration With a Collagen Crosslinked Boston Keratoprosthesis Unit
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Keratolysis Clinical Trial
Vision Restoration With a Collagen Crosslinked Boston Keratoprosthesis Unit
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Keratolysis Clinical Trial
Vision Restoration With a Collagen Crosslinked Boston Keratoprosthesis Unit
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Keratolysis Clinical Trial
Vision Restoration With a Collagen Crosslinked Boston Keratoprosthesis Unit
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Check Point Inhibition After Autologous Stem Cell Transplantation in Patients at High Risk of Post Transplant Recurrence
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Neurology, Oncology Clinical Trial
PET Imaging of Patients Using 124I-PU-AD
Status: Enrolling
Updated: 10/25/2017
Click here to add this to my saved trials
Endocrinology, Oncology Clinical Trial
Cabozantinib-S-Malate in Treating Younger Patients With Recurrent, Refractory, or Newly Diagnosed Sarcomas, Wilms Tumor, or Other Rare Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Oncology Clinical Trial
Cabozantinib-S-Malate in Treating Younger Patients With Recurrent, Refractory, or Newly Diagnosed Sarcomas, Wilms Tumor, or Other Rare Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Oncology Clinical Trial
Cabozantinib-S-Malate in Treating Younger Patients With Recurrent, Refractory, or Newly Diagnosed Sarcomas, Wilms Tumor, or Other Rare Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
We've found
184,457
clinical trials
Neurology, Oncology Clinical Trial
Updated: 12/31/1969
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Updated: 12/31/1969
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Updated: 12/31/1969
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Updated: 12/31/1969
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Updated: 12/31/1969
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Updated: 12/31/1969
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Updated: 12/31/1969
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Updated: 12/31/1969
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Updated: 12/31/1969
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Updated: 12/31/1969
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Updated: 12/31/1969
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Updated: 12/31/1969
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Updated: 12/31/1969
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Updated: 12/31/1969
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Updated: 12/31/1969
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Updated: 12/31/1969
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Updated: 12/31/1969
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Updated: 12/31/1969
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Updated: 12/31/1969
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Updated: 12/31/1969
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Updated: 12/31/1969
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Updated: 12/31/1969
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Updated: 12/31/1969
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Updated: 12/31/1969
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Updated: 12/31/1969
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Updated: 12/31/1969
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Updated: 12/31/1969
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Nivolumab and Yttrium Y 90 Glass Microspheres in Treating Patients With Advanced Liver Cancer
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Neoadjuvant Nivolumab With and Without Urelumab in Patients With Cisplatin-Ineligible Muscle-Invasive Urothelial Carcinoma of the Bladder
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Neoadjuvant Nivolumab With and Without Urelumab in Patients With Cisplatin-Ineligible Muscle-Invasive Urothelial Carcinoma of the Bladder
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Study of Abemaciclib in Dedifferentiated Liposarcoma
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Immunology / Infectious Diseases, Oncology Clinical Trial
Updated: 12/31/1969
Expanded Access Protocol for Tabelecleucel in Subjects With EBV-Associated Viremia or Malignancies
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Immunology / Infectious Diseases, Oncology Clinical Trial
Updated: 12/31/1969
Expanded Access Protocol for Tabelecleucel in Subjects With EBV-Associated Viremia or Malignancies
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Advanced Solid Neoplasms Clinical Trial
Updated: 12/31/1969
A Study of Safety, Pharmacokinetics and Pharmacodynamics of JNJ-64457107 in Participants With Advanced Stage Tumors
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Cystic Fibrosis Clinical Trial
Updated: 12/31/1969
Monitoring Response to Orkambi in Cystic Fibrosis Lung Disease by Inhaled Xenon MRI
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Study of the Efficacy, Safety, and Pharmacokinetics of SM88 in Patients With Prostate Cancer
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology, Orthopedics / Podiatry Clinical Trial
Updated: 12/31/1969
Blepharospasm Tools
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology, Orthopedics / Podiatry Clinical Trial
Updated: 12/31/1969
Blepharospasm Tools
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
A Study of T-VEC (Talimogene Laherparepvec) With or Without Radiotherapy for Melanoma, Merkel Cell Carcinoma, or Other Solid Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Hypoplastic Left Heart Syndrome (HLHS) Clinical Trial
Updated: 4/9/2018
National Collaborative to Improve Care of Children With Complex Congenital Heart Disease
Status: Enrolling,
Phase
Updated: 4/9/2018
Click here to add this to my saved trials
Hypoplastic Left Heart Syndrome (HLHS) Clinical Trial
Updated: 4/9/2018
National Collaborative to Improve Care of Children With Complex Congenital Heart Disease
Status: Enrolling,
Phase
Updated: 4/9/2018
Click here to add this to my saved trials
Hypoplastic Left Heart Syndrome (HLHS) Clinical Trial
Updated: 4/9/2018
National Collaborative to Improve Care of Children With Complex Congenital Heart Disease
Status: Enrolling,
Phase
Updated: 4/9/2018
Click here to add this to my saved trials
Hypoplastic Left Heart Syndrome (HLHS) Clinical Trial
Updated: 4/9/2018
National Collaborative to Improve Care of Children With Complex Congenital Heart Disease
Status: Enrolling,
Phase
Updated: 4/9/2018
Click here to add this to my saved trials
Hypoplastic Left Heart Syndrome (HLHS) Clinical Trial
Updated: 4/9/2018
National Collaborative to Improve Care of Children With Complex Congenital Heart Disease
Status: Enrolling,
Phase
Updated: 4/9/2018
Click here to add this to my saved trials
Hypoplastic Left Heart Syndrome (HLHS) Clinical Trial
Updated: 4/9/2018
National Collaborative to Improve Care of Children With Complex Congenital Heart Disease
Status: Enrolling,
Phase
Updated: 4/9/2018
Click here to add this to my saved trials
Hypoplastic Left Heart Syndrome (HLHS) Clinical Trial
Updated: 4/9/2018
National Collaborative to Improve Care of Children With Complex Congenital Heart Disease
Status: Enrolling,
Phase
Updated: 4/9/2018
Click here to add this to my saved trials
Hypoplastic Left Heart Syndrome (HLHS) Clinical Trial
Updated: 4/9/2018
National Collaborative to Improve Care of Children With Complex Congenital Heart Disease
Status: Enrolling,
Phase
Updated: 4/9/2018
Click here to add this to my saved trials
Hypoplastic Left Heart Syndrome (HLHS) Clinical Trial
Updated: 4/9/2018
National Collaborative to Improve Care of Children With Complex Congenital Heart Disease
Status: Enrolling,
Phase
Updated: 4/9/2018
Click here to add this to my saved trials
Hypoplastic Left Heart Syndrome (HLHS) Clinical Trial
Updated: 4/9/2018
National Collaborative to Improve Care of Children With Complex Congenital Heart Disease
Status: Enrolling,
Phase
Updated: 4/9/2018
Click here to add this to my saved trials
Hypoplastic Left Heart Syndrome (HLHS) Clinical Trial
Updated: 4/9/2018
National Collaborative to Improve Care of Children With Complex Congenital Heart Disease
Status: Enrolling,
Phase
Updated: 4/9/2018
Click here to add this to my saved trials
Glaucoma Clinical Trial
Updated: 12/31/1969
Effectiveness and Safety of Timolol and Dorzolamide Loaded Contact Lenses
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Solid Tumor Cancer Surgery With or Without Intraoperative Imaging: A Registry
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Carcinoma Breast Stage IV Clinical Trial
Updated: 12/31/1969
A Study of Pembrolizumab With Carboplatin and Gemcitabine in Patients With Metastatic Triple Negative Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Carcinoma Breast Stage IV Clinical Trial
Updated: 12/31/1969
A Study of Pembrolizumab With Carboplatin and Gemcitabine in Patients With Metastatic Triple Negative Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Colorectal Cancer Clinical Trial
Updated: 12/1/2016
Evaluation of MM-151 + Nal-IRI + 5-FU + Leucovorin in RAS/RAF Wild-type Metastatic Colorectal Cancer
Status: Enrolling,
Phase
I, II
Updated: 12/1/2016
Click here to add this to my saved trials
Bacterial Infections Clinical Trial
Updated: 12/31/1969
Dose-finding, Pharmacokinetics, and Safety of VABOMERE in Pediatric Subjects With Bacterial Infections
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Hepatocellular Carcinoma Clinical Trial
Updated: 12/31/1969
Study of Pembrolizumab (MK-3475) as Monotherapy in Participants With Advanced Hepatocellular Carcinoma (MK-3475-224/KEYNOTE-224)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Hepatocellular Carcinoma Clinical Trial
Updated: 12/31/1969
Study of Pembrolizumab (MK-3475) as Monotherapy in Participants With Advanced Hepatocellular Carcinoma (MK-3475-224/KEYNOTE-224)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Hepatocellular Carcinoma Clinical Trial
Updated: 12/31/1969
Study of Pembrolizumab (MK-3475) as Monotherapy in Participants With Advanced Hepatocellular Carcinoma (MK-3475-224/KEYNOTE-224)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Hepatocellular Carcinoma Clinical Trial
Updated: 12/31/1969
Study of Pembrolizumab (MK-3475) as Monotherapy in Participants With Advanced Hepatocellular Carcinoma (MK-3475-224/KEYNOTE-224)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Triple Negative Breast Cancer (TNBC) Clinical Trial
Updated: 4/26/2018
Study of Pembrolizumab (MK-3475) Plus Chemotherapy vs. Placebo Plus Chemotherapy for Previously Untreated Locally Recurrent Inoperable or Metastatic Triple Negative Breast Cancer (MK-3475-355/KEYNOTE-355)
Status: Enrolling,
Phase
III
Updated: 4/26/2018
Click here to add this to my saved trials
Triple Negative Breast Cancer (TNBC) Clinical Trial
Updated: 4/26/2018
Study of Pembrolizumab (MK-3475) Plus Chemotherapy vs. Placebo Plus Chemotherapy for Previously Untreated Locally Recurrent Inoperable or Metastatic Triple Negative Breast Cancer (MK-3475-355/KEYNOTE-355)
Status: Enrolling,
Phase
III
Updated: 4/26/2018
Click here to add this to my saved trials
Triple Negative Breast Cancer (TNBC) Clinical Trial
Updated: 4/26/2018
Study of Pembrolizumab (MK-3475) Plus Chemotherapy vs. Placebo Plus Chemotherapy for Previously Untreated Locally Recurrent Inoperable or Metastatic Triple Negative Breast Cancer (MK-3475-355/KEYNOTE-355)
Status: Enrolling,
Phase
III
Updated: 4/26/2018
Click here to add this to my saved trials
Triple Negative Breast Cancer (TNBC) Clinical Trial
Updated: 4/26/2018
Study of Pembrolizumab (MK-3475) Plus Chemotherapy vs. Placebo Plus Chemotherapy for Previously Untreated Locally Recurrent Inoperable or Metastatic Triple Negative Breast Cancer (MK-3475-355/KEYNOTE-355)
Status: Enrolling,
Phase
III
Updated: 4/26/2018
Click here to add this to my saved trials
Triple Negative Breast Cancer (TNBC) Clinical Trial
Updated: 4/26/2018
Study of Pembrolizumab (MK-3475) Plus Chemotherapy vs. Placebo Plus Chemotherapy for Previously Untreated Locally Recurrent Inoperable or Metastatic Triple Negative Breast Cancer (MK-3475-355/KEYNOTE-355)
Status: Enrolling,
Phase
III
Updated: 4/26/2018
Click here to add this to my saved trials
Triple Negative Breast Cancer (TNBC) Clinical Trial
Updated: 4/26/2018
Study of Pembrolizumab (MK-3475) Plus Chemotherapy vs. Placebo Plus Chemotherapy for Previously Untreated Locally Recurrent Inoperable or Metastatic Triple Negative Breast Cancer (MK-3475-355/KEYNOTE-355)
Status: Enrolling,
Phase
III
Updated: 4/26/2018
Click here to add this to my saved trials
Triple Negative Breast Cancer (TNBC) Clinical Trial
Updated: 4/26/2018
Study of Pembrolizumab (MK-3475) Plus Chemotherapy vs. Placebo Plus Chemotherapy for Previously Untreated Locally Recurrent Inoperable or Metastatic Triple Negative Breast Cancer (MK-3475-355/KEYNOTE-355)
Status: Enrolling,
Phase
III
Updated: 4/26/2018
Click here to add this to my saved trials
Triple Negative Breast Cancer (TNBC) Clinical Trial
Updated: 4/26/2018
Study of Pembrolizumab (MK-3475) Plus Chemotherapy vs. Placebo Plus Chemotherapy for Previously Untreated Locally Recurrent Inoperable or Metastatic Triple Negative Breast Cancer (MK-3475-355/KEYNOTE-355)
Status: Enrolling,
Phase
III
Updated: 4/26/2018
Click here to add this to my saved trials
Triple Negative Breast Cancer (TNBC) Clinical Trial
Updated: 4/26/2018
Study of Pembrolizumab (MK-3475) Plus Chemotherapy vs. Placebo Plus Chemotherapy for Previously Untreated Locally Recurrent Inoperable or Metastatic Triple Negative Breast Cancer (MK-3475-355/KEYNOTE-355)
Status: Enrolling,
Phase
III
Updated: 4/26/2018
Click here to add this to my saved trials
Clinical Trial
Updated: 8/3/2016
Changes in Footwear Comfort and Performance in High School Football Players
Status: Enrolling
Updated: 8/3/2016
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Olaparib With or Without Atezolizumab in Treating Patients With Locally Advanced or Metastatic Non-HER2-Positive Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Olaparib With or Without Atezolizumab in Treating Patients With Locally Advanced or Metastatic Non-HER2-Positive Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Olaparib With or Without Atezolizumab in Treating Patients With Locally Advanced or Metastatic Non-HER2-Positive Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Olaparib With or Without Atezolizumab in Treating Patients With Locally Advanced or Metastatic Non-HER2-Positive Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Olaparib With or Without Atezolizumab in Treating Patients With Locally Advanced or Metastatic Non-HER2-Positive Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Olaparib With or Without Atezolizumab in Treating Patients With Locally Advanced or Metastatic Non-HER2-Positive Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Olaparib With or Without Atezolizumab in Treating Patients With Locally Advanced or Metastatic Non-HER2-Positive Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Olaparib With or Without Atezolizumab in Treating Patients With Locally Advanced or Metastatic Non-HER2-Positive Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Alzheimer Disease Clinical Trial
Updated: 12/31/1969
BI 425809 in Patients With Cognitive Impairment Due to Alzheimer's Disease.
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Alzheimer Disease Clinical Trial
Updated: 12/31/1969
BI 425809 in Patients With Cognitive Impairment Due to Alzheimer's Disease.
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Alzheimer Disease Clinical Trial
Updated: 12/31/1969
BI 425809 in Patients With Cognitive Impairment Due to Alzheimer's Disease.
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Alzheimer Disease Clinical Trial
Updated: 12/31/1969
BI 425809 in Patients With Cognitive Impairment Due to Alzheimer's Disease.
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Schizophrenia Clinical Trial
Updated: 12/31/1969
Clinical Trial of BI 425809 Effect on Cognition and Functional Capacity in Schizophrenia
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Schizophrenia Clinical Trial
Updated: 12/31/1969
Clinical Trial of BI 425809 Effect on Cognition and Functional Capacity in Schizophrenia
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Schizophrenia Clinical Trial
Updated: 12/31/1969
Clinical Trial of BI 425809 Effect on Cognition and Functional Capacity in Schizophrenia
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Optune Delivered Electric Field Therapy and Bevacizumab in Treating Patients With Recurrent or Progressive Grade 2 or 3 Meningioma
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
RHEUMATOID ARTHRITIS Clinical Trial
Updated: 12/31/1969
The Corrona RA Data Collection Program
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Pancreatic Cancer Clinical Trial
Updated: 4/23/2018
Phase II Randomized Trial of mFOLFIRINOX +/- Ramucirumab in Advanced Pancreatic Cancer
Status: Enrolling,
Phase
II
Updated: 4/23/2018
Click here to add this to my saved trials
Hantaan Virus Clinical Trial
Updated: 12/31/1969
A Single-blind Study to Evaluate the Safety, Tolerability, and Immunogenicity of a Hantaan Puumala Virus DNA Vaccine
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Knee Osteoarthritis Clinical Trial
Updated: 10/11/2017
Liposomal Bupivacaine vs Adductor Canal Block in Total Knee Arthroplasty
Status: Enrolling,
Phase
IV
Updated: 10/11/2017
Click here to add this to my saved trials
Keratolysis Clinical Trial
Updated: 12/31/1969
Vision Restoration With a Collagen Crosslinked Boston Keratoprosthesis Unit
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Keratolysis Clinical Trial
Updated: 12/31/1969
Vision Restoration With a Collagen Crosslinked Boston Keratoprosthesis Unit
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Keratolysis Clinical Trial
Updated: 12/31/1969
Vision Restoration With a Collagen Crosslinked Boston Keratoprosthesis Unit
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Keratolysis Clinical Trial
Updated: 12/31/1969
Vision Restoration With a Collagen Crosslinked Boston Keratoprosthesis Unit
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Keratolysis Clinical Trial
Updated: 12/31/1969
Vision Restoration With a Collagen Crosslinked Boston Keratoprosthesis Unit
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Updated: 12/31/1969
Check Point Inhibition After Autologous Stem Cell Transplantation in Patients at High Risk of Post Transplant Recurrence
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Neurology, Oncology Clinical Trial
Updated: 10/25/2017
PET Imaging of Patients Using 124I-PU-AD
Status: Enrolling
Updated: 10/25/2017
Click here to add this to my saved trials
Endocrinology, Oncology Clinical Trial
Updated: 12/31/1969
Cabozantinib-S-Malate in Treating Younger Patients With Recurrent, Refractory, or Newly Diagnosed Sarcomas, Wilms Tumor, or Other Rare Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Oncology Clinical Trial
Updated: 12/31/1969
Cabozantinib-S-Malate in Treating Younger Patients With Recurrent, Refractory, or Newly Diagnosed Sarcomas, Wilms Tumor, or Other Rare Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Oncology Clinical Trial
Updated: 12/31/1969
Cabozantinib-S-Malate in Treating Younger Patients With Recurrent, Refractory, or Newly Diagnosed Sarcomas, Wilms Tumor, or Other Rare Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials